Dr. Kucuk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5665 Peachtree Dunwoody Rd
Atlanta, GA 30342Phone+1 678-843-7001Fax+1 404-851-7339
Summary
- Dr. Omer Kucuk is an oncologist in Atlanta, GA and is affiliated with multiple hospitals in the area, including Emory University Hospital, Emory University Hospital Midtown, Grady Memorial Hospital, and Emory Saint Joseph's Hospital of Atlanta. He received his medical degree from Hacettepe University Faculty of Medicine and has been in practice 42 years. He specializes in genitourinary oncology and is experienced in prostate cancer, urinary bladder cancer, kidney cancer and testis cancer.
Education & Training
McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 1980 - 1981
Presence Saint Francis HospitalFellowship, Hematology and Medical Oncology, 1979 - 1980- Presence Saint Francis HospitalFellowship, Hematology, 1978 - 1979
Ascension Illinois/Saint FrancisResidency, Internal Medicine, 1975 - 1978
Hacettepe University FOMClass of 1975
Certifications & Licensure
HI State Medical License 1991 - 2026
GA State Medical License 2008 - 2025
MI State Medical License 1977 - 2024
IL State Medical License 1977 - 2014- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- Atlanta Magazine: Top Doctors Castle Connolly, 2010-2014
- America's Top Doctors for Cancer Castle Connolly, 2009-2013
- Join now to see all
Clinical Trials
- SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth Start of enrollment: 1997 Dec 01
- Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer Start of enrollment: 2000 Dec 18
- Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia Start of enrollment: 2003 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsClinical Outcomes and Racial Disparities in Metastatic Hormone-Sensitive Prostate Cancer in the Era of Novel Treatment Options.Katherine Emilie Rhoades Smith, Jacqueline T. Brown, Limeng Wan, Yuan Liu, Greta Russler
The Oncologist. 2021-06-29 - 14 citationsTreatment of men with high-risk prostate cancer based on race, insurance coverage, and access to advanced technologyRobert Steven Gerhard, Dattatraya Patil, Yuan Liu, Kenneth Ogan, Mehrdad Alemozaffar
Urologic Oncology. 2017-05-01 - 55 citationsDocetaxel-induced polyploidization may underlie chemoresistance and disease relapseAngela Ogden, Padmashree C.G. Rida, Beatrice S. Knudsen, Omer Kucuk, Ritu Aneja
Cancer Letters. 2015-10-28
Journal Articles
- The Addition of Chemotherapy in the Definitive Management of High Risk Prostate CancerBradley C Carthon, Mehmet A Bilen, Omer Kucuk, Urologic Oncology
Authored Content
- Retraction Notice to: Sensitization of Squamous Cell Carcinoma to Cisplatin Induced Killing by Natural AgentsMarch 2018
Press Mentions
Angelina Jolie's Doctor Urges Women to UP Their Soya Intake, Devour More of One Type of Fruit and Ditch Anti-Bacterial Soap as She Shares Her Top 10 Tips to Prevent Breast CancerOctober 6th, 2017- Soy Products Are GOOD for Fighting Breast Cancer, Study Finds - After Confusing One-off Research Said the OppositeMarch 8th, 2017
Winship Expert Touts Soy Use in the Journal CancerMarch 6th, 2017- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
